The field of the present disclosure relates generally to medication packaging and, more specifically, to a child-resistant medication container assembly for storing a plurality of dosages of medication therein, for dispensing the dosages from the container, and for providing information related to administration of the medication integrated with the container assembly.
To receive prescription medicines, patients need to acquire a prescription prepared by a person authorized to prescribe medicine. A prescription medicine is then dispensed by a pharmacist, and the prescription medicine typically comes with an information leaflet providing information about the medicine, its side effects, if any, instructions for use of the medicine, and any relevant cautions and warnings.
Most prescription medicines are dispensed by a pharmacist in a bottle or in a blister card. Some prescription medicines that are dispensed in this manner have complicated instructions for use and may not be easy for a patient to remember. For example, some prescription medicines are to be taken in the morning, afternoon, or evening, some with or without food, some with or without certain types of food, and in particular quantities. In these situations, a patient may need to read the bottle, or compliance pack, or refer back to the information leaflet for instructions when taking the medicine. A patient also may need to keep a log of when he or she took the medicine to ensure compliance with any timing instructions.
In one aspect, a child-resistant medication container assembly is provided. The assembly includes a blister card including a plurality of compartments each configured to support a dosage of medication, and a puck including a body portion, a recess that defines a partition wall in the body portion, and a plurality of openings defined in the partition wall. Each opening corresponds to one of the plurality of compartments in the blister card. The assembly further includes a carton including a first wall opposite a second wall. An access opening is defined in the first wall and a plurality of perforations are defined in the second wall. The access opening is sized to provide access to the plurality of compartments, and each perforation corresponds to one of the plurality of compartments in the blister card.
In another aspect, a method of assembling a child-resistant medication container assembly is provided. The method includes aligning a blister card, including a plurality of compartments each configured to support a dosage of medication, with a puck that includes a body portion, a recess that defines a partition wall in the body portion, and a plurality of openings defined in the partition wall. Each opening corresponds to one of the plurality of compartments in the blister card when the blister card is aligned with the puck. The method further includes attaching the blister card to the puck to form a puck assembly, and positioning the puck assembly within a carton that includes a first wall opposite a second wall. An access opening is defined in the first wall and a plurality of perforations are defined in the second wall. The access opening is sized to provide access to the plurality of compartments, and each perforation corresponds to one of the plurality of compartments in the blister card. The method also includes closing the carton to enclose the puck assembly therein.
In yet another aspect, a method of dispensing medication secured within a child-resistant medication container assembly to a user is provided. The method includes providing the child-resistant medication container assembly including a carton, a puck, and a blister card, wherein the blister card is secured to the puck and the puck is secured to the carton. The method further includes applying a force to at least one compartment of a plurality of compartments of the blister card, wherein the plurality of compartments are accessible through an access opening in a first wall of the carton, and breaking a seal of the at least one compartment such that a dosage of medication contained therein is discharged through an opening in the puck and through an opening in a second wall of the carton. The opening in the second wall of the carton is defined by a perforation in the second wall.
The following detailed description illustrates the disclosure by way of example and not by way of limitation. The description enables one skilled in the art to make and use the disclosure, describes several embodiments, adaptations, variations, alternatives, and use of the disclosure, including what is presently believed to be the best mode of carrying out the disclosure.
Embodiments of the present disclosure relate to a child-resistant medication container assembly for storing a plurality of dosages of medication therein, for dispensing the dosages from the container, and for providing information related to administration of the medication integrated with the container assembly. The container assembly includes a carton and a puck assembly positioned within the carton. The puck assembly is formed from a puck that is rigid and capable of supporting a blister card having a plurality of compartments. Each compartment is sized to store a dosage of medication therein. When a consumer is ready to access the dosage of medication in one of the compartments, the consumer opens the carton to gain access to the puck assembly. For example, in one embodiment, the carton includes a first wall having an access opening defined therein, and a second wall having a plurality of perforations defined therein. Each perforation corresponds to one of the compartments in the blister card. Thus, the consumer accesses the plurality of compartments through the access opening, applies a force to the desired compartment, breaks a seal in the blister card that covers the desired compartment, and then forces the dosage through the corresponding perforation in the second wall of the carton to dispense the dosage of medication from the container assembly. As used herein, the term “user” or “consumer” means a person or person(s) who is consuming or using contents from the container assembly (e.g. a patient), a healthcare provider, and/or a patient assistant providing the contents from the container to the person(s) consuming the contents from the container. As used herein, the term “puck” is a term used by those skilled in the art, and generally refers to an object having a rigid body that substantially maintains its shape when a manual force is applied thereto.
The access opening is sized larger than an individual compartment in the blister card such that the first wall of the carton does not act as either a visual or physical hindrance to applying a force to the compartment with the user's finger when dispensing the dosage of medication from the container assembly. Moreover, no portion of the first wall extends across the access opening, thereby reducing the likelihood that the first wall will become damaged when attempting to access the plurality of compartments through the access opening. A damaged first wall may reduce the aesthetic appearance of the carton, and/or may act as an impediment to closing the cover of the carton when not in use.
In one embodiment, the container assembly is configured to be conveniently sized and portable, but also large enough to carry a sufficient amount of dosages to sustain the user for an extended period of time. For example, the carton has a generally thin profile such that it is capable of being placed within a pocket or a handbag of the user. As such, the user has the ability to carry the container assembly with them and administer a dosage of medication whenever it is convenient to do so. Moreover, as noted above, the blister card includes a plurality of compartments such that a user need only carry as many container assemblies as needed (e.g., one per week, or more than one if traveling for extended durations) rather than an entire prescription's worth of medication.
As noted above, the container assembly also includes information related to administration of the medication integrated with the carton. For example, in one embodiment, the blister card includes a number of compartments that is a multiple of the number of days in a week (e.g., 7, 14, or 21 compartments), and each compartment, or groupings of compartments, are labeled according to respective days of the week. In one embodiment, the container assembly also includes an informational panel adhered to a cover of the carton that overlays the first wall when in a closed position. The informational panel is positioned such that when the cover is in an open position, the user is provided with access to the plurality of compartments of the blister card and is also provided with a view of the instructional panel simultaneously. As such, the container assembly includes information that is conveniently located, easily discernible, and difficult to miss.
In one embodiment, the container assembly, an overpack carton, and/or blanks for forming the container assembly or the overpack carton, may include at least one marking thereon including, without limitation, indicia that communicates the product, a manufacturer of the product, and/or a seller of the product. For example, the marking may include printed text that indicates a product's name and briefly describes the product, logos and/or trademarks that indicate a manufacturer and/or seller of the product, and/or designs and/or ornamentation that attract attention. In another embodiment, the container assembly is void of markings, such as, without limitation, indicia that communicates the product, a manufacturer of the product, and/or a seller of the product. Furthermore, the container assembly and/or overpack carton may have any suitable size, shape, and/or configuration (i.e., number of sides), whether such sizes, shapes, and/or configurations are described and/or illustrated herein. For example, in one embodiment, the container assembly includes a shape that provides functionality, such as a shape that enables the container assembly to be easily transportable during every day use.
Referring now to the drawings,
Carton 102 also includes a second wall 182 (shown in
Referring to
In the example embodiment, access opening 114 is sized to correspond to an upper perimeter of a recess of puck 106, as will be explained in more detail below. In other words, access opening 114 is sized such that an inner side edge 131 of access opening 114 does not extend past the upper perimeter edge of the recess of puck 106. In one embodiment, inner side edge 131 defines a frame about the plurality of compartments 116. In addition, access opening 114 is sized such that the plurality of compartments 116 are accessible through access opening 114 simultaneously. For example, access opening 114 is free of impediments, and does not have a portion of first wall 112 extending thereacross such that more than one compartment 116 is accessible through access opening 114 without manipulating the shape of carton 102 or of puck 106.
In one embodiment, carton 102 also includes a removable panel 132 adhered to third wall 120. Removable panel 132 is initially secured to first wall 112 when third wall 120 is in the closed position and container assembly 100 is in its initially secured state. More specifically, removable panel 132 is initially secured to first wall 112 with a plurality of connector tabs 134 disposed about a periphery of access opening 114. The plurality of connector tabs 134 are broken when third wall 120 is rotated from the closed position, as shown in
Referring to
Referring to
Referring to
In the example embodiment, body portion 136 of puck 106 includes a first end 152 and a second end 154. Side walls 144 at first end 152 are angled inwardly relative to a longitudinal centerline of body portion 136 to define a taper at first end 152 of body portion 136. As such, first end 152 has a reduced width, which enables puck 106 to be inserted into an open end of carton 102 more easily. In addition, in the example embodiment, side walls 144 at first end 152 and second end 154 are both formed with a ribbed surface 156. Ribbed surface 156 provides a greater surface area for the application of adhesive to puck 106 when securing puck 106 to carton 102.
Referring to
In the example embodiment, container assembly 100 is fitted with a blister card 108 that includes seven compartments 116 when container assembly 100 is configured for storing and dispensing medication that needs to be administered once a day. As such, container assembly 100 is capable of storing and dispensing a week's worth of medication using a thin and portable container such that a user need not carry a whole prescription's worth of medication with them when not at a primary storage location for the prescription.
The plurality of compartments 116 of the blister card 108 may have a variety of sizes and shapes in order to accommodate different types, sizes, and doses of medication. For example, compartments 116 may be circular, ovular, cuboidal, rectangular, and the like. Similarly, blister card 108 may include compartments 116 including any suitable combination of shapes and sizes. In other words, because a dosage 118 of medication in the form of a pill or capsule may have many sizes and shapes, blister card 108 can be manufactured to accommodate the specific size and shape of one or more types of medication. Further, many medications are adapted to be taken multiple times a day, at specific times of the day, and/or in combination with other medications. Therefore, compartments 116 may be sized, shaped, and arranged to store medications in any suitable orientation to specify an order or series of administration, for example, such as in the alternative container assembly embodiment that will be described in more detail below. The plurality of compartments 116 may be sized and shaped to allow easy access to and removal of the dosage 118 of medication from the plurality of compartments.
Referring again to
Referring to
First wall 112 includes a first end flap 188 and a second end flap 190 extending from opposing sides of first wall 112. First end flap 188 and second end flap 190 each include a plurality of score lines 192 defined therein. First wall 112 also includes perforated cutout 194 for defining removable panel 132. More specifically, a plurality of connector tabs 134 define perforated cutout 194, and connector tabs 134 facilitate separation of removable panel 132 from first wall 112.
First side wall 180 includes a first auxiliary tab 196 and a second auxiliary tab 198 extending from opposing sides of first side wall 180. Likewise, second side wall 184 includes a first auxiliary tab 200 and a second auxiliary tab 202 extending from opposing sides of second side wall 184. First side wall 180 further includes a contoured cut line 204 defined therein that at least partially extends between first wall 112 and first side wall 180. Contoured cut line 204 is formed in blank 168 to facilitate defining tab slot 128 (shown in
Second wall 182 includes a first end flap 208 and a second end flap 210 extending from opposing sides of second wall 182. When forming carton 102, first end flap 188, second end flap 190, first auxiliary tab 196, second auxiliary tab 198, first auxiliary tab 200, second auxiliary tab 202, first end flap 208, and second end flap 210 are joined together in a glued-end construction to define end walls of carton 102. Second wall 182 also includes a plurality of perforations 212 defined therein. When carton 102 is formed, first wall 112 is opposite second wall 182, and each perforation 212 corresponds to one of the plurality of compartments 116 in blister card 108 (both shown in
Second joining flap 186 includes securing tab 130 and the pair of breakaway tabs 124 positioned on opposing sides of securing tab 130. As noted above, breakaway tabs 124 are coupled to third wall 120 with at least one connector tab 126. In addition, breakaway tabs 124 are coupled to securing tab 130 with at least one connector tab 214. Thus, to position third wall 120 in an open position from an initially secured state, having breakaway tabs 124 adhered to adhesive zones 206, a user breaks connector tab 214 to separate securing tab 130 from breakaway tabs 124, breaks connector tabs 126 to separate third wall 120 from breakaway tabs 124, and rotates third wall 120 about a line of weakness 216 defined between second side wall 184 and third wall 120. Line of weakness 216 enables third wall 120 to optionally be separated from container assembly 100, which facilitates providing unimpeded access to blister card 108 through access opening 114 as shown in
Referring to
Likewise, referring to
In the example embodiment, container assembly 232 is fitted with blister card 240 that includes fourteen compartments 258 when container assembly 232 is configured for storing and dispensing medication that needs to be administered twice a day. For example, referring again to
In one embodiment, label insert 242 is color-coded, or otherwise provided with distinguishing markings, to facilitate distinguishing between the medication contained in first row 260 and in second row 262. In some examples, the label insert may include multiple zones to indicate, different dosage times. In the example embodiment, label insert 242 includes a first zone 264 having a first color and a second zone 266 having a second color. First zone 264 is configured to align with first row 260 and second zone 266 is configured to align with second row 262 when label insert 242 is coupled to puck 238. Moreover, in one embodiment, a first wall 268 (shown in
Referring to
This written description uses examples to disclose various implementations, including the best mode, and also to enable any person skilled in the art to practice the various implementations, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the disclosure is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal language of the claims.
This application is a continuation application and claims priority to U.S. patent application Ser. No. 15/928,943, filed Mar. 22, 2018, entitled “MEDICINE CONTAINER, METHOD OF ASSEMBLING THE CONTAINER, AND METHOD OF DISPENSING THE MEDICINE FROM THE CONTAINER,” which is incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
D97936 | Neumann-Holste | Dec 1935 | S |
3288281 | Sparks | Nov 1966 | A |
3305077 | Martin et al. | Feb 1967 | A |
3911606 | Hunkins | Oct 1975 | A |
3921804 | Tester | Nov 1975 | A |
RE29705 | Compere | Jul 1978 | E |
4120400 | Kotyuk | Oct 1978 | A |
D254219 | Papciak | Feb 1980 | S |
4192422 | Kotyuk | Mar 1980 | A |
D261198 | Altadonna | Oct 1981 | S |
D263559 | Poore | Mar 1982 | S |
D264538 | Pomroy | May 1982 | S |
4340141 | Fischer | Jul 1982 | A |
D266147 | Mcintosh et al. | Sep 1982 | S |
D267767 | Storrs | Feb 1983 | S |
D268130 | Easton | Mar 1983 | S |
D276116 | Basil | Oct 1984 | S |
D293887 | Webster | Jan 1988 | S |
4838444 | Bitel | Jun 1989 | A |
5050739 | Hannan et al. | Sep 1991 | A |
D320930 | Richards | Oct 1991 | S |
D322400 | Sorensen | Dec 1991 | S |
D322934 | Kalvelage | Jan 1992 | S |
D324819 | Eisenberg | Mar 1992 | S |
5109984 | Romick | May 1992 | A |
D327363 | Farb | Jun 1992 | S |
D331258 | Tarozzi | Nov 1992 | S |
D350478 | Fuller et al. | Sep 1994 | S |
D351995 | Kalvelage | Nov 1994 | S |
D351996 | Kalvelage | Nov 1994 | S |
5489025 | Romick | Feb 1996 | A |
D370414 | Lambelet | Jun 1996 | S |
D370625 | Kelsey et al. | Jun 1996 | S |
D372124 | Dammers | Jul 1996 | S |
D372867 | Lambelet | Aug 1996 | S |
D382474 | Malmborg | Aug 1997 | S |
5740717 | Sowden et al. | Apr 1998 | A |
5785180 | Dressel et al. | Jul 1998 | A |
D404641 | Kelsey et al. | Jan 1999 | S |
5878888 | Faughey et al. | Mar 1999 | A |
D411445 | Anderson | Jun 1999 | S |
D414106 | Anderson | Sep 1999 | S |
D414409 | Sanfilippo et al. | Sep 1999 | S |
6082544 | Romick | Jul 2000 | A |
6138830 | Muggli | Oct 2000 | A |
D434558 | Brady et al. | Dec 2000 | S |
6273260 | Coldepietro et al. | Aug 2001 | B1 |
D448048 | Brown | Sep 2001 | S |
D457246 | Mazel et al. | May 2002 | S |
6443307 | Burridge | Sep 2002 | B1 |
6516949 | Fuller et al. | Feb 2003 | B2 |
6622856 | Gallo et al. | Sep 2003 | B2 |
D480958 | Mazel et al. | Oct 2003 | S |
6659280 | Paliotta et al. | Dec 2003 | B2 |
6679382 | Kancsar et al. | Jan 2004 | B1 |
D485979 | Chue | Feb 2004 | S |
6793077 | Kancsar et al. | Sep 2004 | B1 |
6896139 | Kancsar et al. | May 2005 | B2 |
6951282 | Jones | Oct 2005 | B2 |
D514308 | Wahl et al. | Feb 2006 | S |
6997320 | Kancsar et al. | Feb 2006 | B1 |
D518737 | Zalzal | Apr 2006 | S |
7063211 | Williams-Hartman | Jun 2006 | B2 |
D525024 | Fridie et al. | Jul 2006 | S |
D525777 | Priebe et al. | Aug 2006 | S |
D526478 | Priebe et al. | Aug 2006 | S |
7126879 | Snyder | Oct 2006 | B2 |
7188728 | Williams-Hartman | Mar 2007 | B2 |
D546198 | Currie et al. | Jul 2007 | S |
7243798 | Buss | Jul 2007 | B2 |
D558603 | Priebe et al. | Jan 2008 | S |
7360652 | Arnold | Apr 2008 | B2 |
D570095 | Ullersted et al. | Jun 2008 | S |
7401702 | Hession | Jul 2008 | B2 |
D574665 | James | Aug 2008 | S |
7448496 | Williams-Hartman | Nov 2008 | B2 |
7497331 | Pham | Mar 2009 | B2 |
D600503 | Ragsdale et al. | Sep 2009 | S |
7641050 | Klatt et al. | Jan 2010 | B2 |
7665610 | Williams-Hartman | Feb 2010 | B2 |
D612594 | Wade et al. | Mar 2010 | S |
D613153 | Russell | Apr 2010 | S |
7696236 | Bradford | Apr 2010 | B2 |
7699173 | Hession | Apr 2010 | B2 |
7735650 | Zumbiel | Jun 2010 | B2 |
D619257 | Meschenmoser et al. | Jul 2010 | S |
D620260 | Emmert | Jul 2010 | S |
7748535 | Grosskopf | Jul 2010 | B2 |
D621151 | Richardson | Aug 2010 | S |
D622158 | Proulx | Aug 2010 | S |
7767700 | Bradford | Aug 2010 | B2 |
7780007 | Baker | Aug 2010 | B2 |
7784250 | Grosskopf | Aug 2010 | B2 |
7891492 | Wenninger et al. | Feb 2011 | B2 |
7900772 | Sack et al. | Mar 2011 | B2 |
7905355 | Williams-Hartman | Mar 2011 | B2 |
7926660 | Jones et al. | Apr 2011 | B2 |
D637391 | Stevens et al. | May 2011 | S |
7967144 | Sack et al. | Jun 2011 | B2 |
D642789 | Cooper | Aug 2011 | S |
7997411 | Williams-Hartman | Aug 2011 | B2 |
8011512 | Brollier et al. | Sep 2011 | B2 |
D650295 | Schmitz et al. | Dec 2011 | S |
8091708 | Loftin et al. | Jan 2012 | B2 |
8132671 | Hession | Mar 2012 | B2 |
D658991 | Schmitz et al. | May 2012 | S |
D659019 | Specker et al. | May 2012 | S |
D659550 | Mazor | May 2012 | S |
8205752 | Sack et al. | Jun 2012 | B2 |
D663981 | Purcell et al. | Jul 2012 | S |
D669311 | Hsu | Oct 2012 | S |
D670178 | Carson | Nov 2012 | S |
8317017 | Edwards et al. | Nov 2012 | B2 |
D673297 | Hawker | Dec 2012 | S |
8342330 | Weston et al. | Jan 2013 | B2 |
8342331 | Ziemba et al. | Jan 2013 | B2 |
8403212 | Van Esch | Mar 2013 | B2 |
D680318 | Denzinger | Apr 2013 | S |
8413813 | Grosskopf | Apr 2013 | B2 |
8420674 | Bradford | Apr 2013 | B2 |
D683950 | Ernster et al. | Jun 2013 | S |
D684482 | Stevens | Jun 2013 | S |
D685272 | Stevens | Jul 2013 | S |
8479921 | Ingraham | Jul 2013 | B2 |
D688570 | Logue | Aug 2013 | S |
D688571 | Logue | Aug 2013 | S |
8499531 | Benetti et al. | Aug 2013 | B2 |
D689373 | Logue | Sep 2013 | S |
D689374 | Logue | Sep 2013 | S |
D689778 | Logue | Sep 2013 | S |
D691465 | O'Brien et al. | Oct 2013 | S |
D691856 | Dabney-Wiggs | Oct 2013 | S |
8544650 | Williams-Hartman | Oct 2013 | B2 |
8550248 | Busen | Oct 2013 | B1 |
8556077 | Hanley | Oct 2013 | B1 |
8561798 | Hession | Oct 2013 | B2 |
8567606 | Bellamah et al. | Oct 2013 | B2 |
8573403 | Stevens et al. | Nov 2013 | B2 |
8579106 | Naik et al. | Nov 2013 | B2 |
8584857 | Ozawa et al. | Nov 2013 | B2 |
D694904 | Banes et al. | Dec 2013 | S |
8602218 | Grosskopf | Dec 2013 | B2 |
8607982 | Jones | Dec 2013 | B2 |
8607983 | Niven et al. | Dec 2013 | B2 |
D697095 | Chan | Jan 2014 | S |
8627957 | Ziemba et al. | Jan 2014 | B2 |
8640917 | Kracke | Feb 2014 | B2 |
D700773 | Lupkas | Mar 2014 | S |
8672134 | Sprada et al. | Mar 2014 | B2 |
8740003 | Elliott | Jun 2014 | B2 |
8746454 | Doucet et al. | Jun 2014 | B2 |
8752704 | Leon Alonso | Jun 2014 | B2 |
8757381 | Bouthiette | Jun 2014 | B2 |
D708760 | Smeja | Jul 2014 | S |
D708761 | Smeja | Jul 2014 | S |
D708762 | Smeja | Jul 2014 | S |
D711219 | Palsson | Aug 2014 | S |
D713051 | Smeja | Sep 2014 | S |
D719216 | Jansen et al. | Dec 2014 | S |
D723279 | Wax | Mar 2015 | S |
D723390 | Eriksson et al. | Mar 2015 | S |
8991607 | Wagner et al. | Mar 2015 | B2 |
D731171 | Upchurch et al. | Jun 2015 | S |
D731782 | Upchurch et al. | Jun 2015 | S |
9241873 | Upchurch | Jan 2016 | B2 |
9408777 | Choubey | Aug 2016 | B2 |
D770303 | Gelbaum | Nov 2016 | S |
D772559 | Binder et al. | Nov 2016 | S |
D787812 | Ganesan et al. | May 2017 | S |
D806570 | Gelbaum | Jan 2018 | S |
D831330 | Kim et al. | Oct 2018 | S |
D833734 | Binder et al. | Nov 2018 | S |
D874921 | Zhao | Feb 2020 | S |
D876819 | Kim et al. | Mar 2020 | S |
D877625 | Loprete et al. | Mar 2020 | S |
D882243 | Marshall et al. | Apr 2020 | S |
D896068 | Hampton et al. | Sep 2020 | S |
20030034271 | Burridge | Feb 2003 | A1 |
20030042167 | Balz et al. | Mar 2003 | A1 |
20030164380 | Taneja et al. | Sep 2003 | A1 |
20060163110 | Adler et al. | Jul 2006 | A1 |
20070185615 | Bossi et al. | Aug 2007 | A1 |
20090038982 | Doucet | Feb 2009 | A1 |
20090242451 | Kessler | Oct 2009 | A1 |
20090301924 | Rondeau | Dec 2009 | A1 |
20110215022 | Sack et al. | Sep 2011 | A1 |
20120248005 | Bergey | Oct 2012 | A1 |
20120261275 | Intini | Oct 2012 | A1 |
20130008825 | Mcarthur et al. | Jan 2013 | A1 |
20130193029 | Weston et al. | Aug 2013 | A1 |
20130220870 | Grosskopf | Aug 2013 | A1 |
20130220871 | Bradford | Aug 2013 | A1 |
20130233756 | Weston et al. | Sep 2013 | A1 |
20130256183 | Ingraham | Oct 2013 | A1 |
20130281960 | Hanley | Oct 2013 | A1 |
20130306511 | Branyon et al. | Nov 2013 | A1 |
20140001194 | Pipes et al. | Jan 2014 | A1 |
20140027340 | Hession | Jan 2014 | A1 |
20140027341 | Ludwig et al. | Jan 2014 | A1 |
20140083900 | Ziemba et al. | Mar 2014 | A1 |
20140171436 | Kamen et al. | Jun 2014 | A1 |
20140183095 | Choubey et al. | Jul 2014 | A1 |
20140209498 | Stevens | Jul 2014 | A1 |
20140214438 | Ahmadi | Jul 2014 | A1 |
20140216968 | Wagner et al. | Aug 2014 | A1 |
20140216977 | Bowers et al. | Aug 2014 | A1 |
20150014203 | Upchurch et al. | Jan 2015 | A1 |
20160367436 | Upchurch et al. | Dec 2016 | A1 |
20170014306 | Rousselet | Jan 2017 | A1 |
20170107038 | Kim et al. | Apr 2017 | A1 |
20170112719 | O'Dwyer et al. | Apr 2017 | A1 |
20170239144 | Terhune et al. | Aug 2017 | A1 |
20180000691 | Terhune et al. | Jan 2018 | A1 |
20190290542 | Marshall et al. | Sep 2019 | A1 |
Number | Date | Country |
---|---|---|
314244 | May 2007 | AU |
341384 | Mar 2012 | AU |
346153 | Jan 2013 | AU |
348282 | May 2013 | AU |
357121 | Aug 2014 | AU |
359486 | Dec 2014 | AU |
114356 | Mar 2008 | CA |
120646 | Mar 2008 | CA |
1211191 | Jun 2002 | EP |
1481914 | Dec 2004 | EP |
3016886 | May 2016 | EP |
2003221067 | Aug 2003 | JP |
2005120984 | Dec 2005 | WO |
2010015638 | Feb 2010 | WO |
2014057967 | Apr 2014 | WO |
2014085625 | Jun 2014 | WO |
Entry |
---|
PCT International Search Report and Written Opinion, Application No. PCT/US2019/022853, dated Jul. 2, 2019, 15 pages. |
Number | Date | Country | |
---|---|---|---|
20220008290 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15928943 | Mar 2018 | US |
Child | 17319917 | US |